Developer of an AI-driven cancer biology platform designed to predict how therapies will perform in patients. Genialis is based in Boston, MA. Its last reported valuation was $37 million in Jan 2023. It has raised $16.4 million across 2 recorded rounds; the latest was a $700,000 seed round in Dec 2025.
Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$16.4M
Last round
Seed Round
Dec 2025
Cap table — not yet on record
Genialis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genialis with a free account
·Watch Genialis: the Monday email on marks, rounds and moves